NCT02207127

Brief Summary

There is a fundamental gap in the investigators ability to design effective surgical treatment of obstructive sleep apnea (OSA) for the 30-40% of patients who cannot tolerate non-surgical treatment. OSA surgery outcomes vary widely, with the chances of a successful outcome ranging from 5% to 65% for individual or combination procedures. To predict - and thereby to improve - outcomes, the investigators must determine what predicts surgical success. This project will compare findings from two evaluations: drug-induced sleep endoscopy (DISE) and upper airway magnetic resonance imaging (MRI). DISE has demonstrated important benefits, but it has important limitations. Upper airway MRI is the most complete evaluation performed during wakefulness, making it conducive to broad application and less expensive than DISE, but there are no studies utilizing MRI as a surgical evaluation. The investigators propose a cross-sectional analysis of 40 adult subjects with moderate to severe OSA. In addition to history, physical examination, and polysomnogram (sleep study), all subjects will undergo DISE and MRI to characterize the pattern of obstruction. The investigators will examine the association between DISE and MRI, focusing on specific DISE findings that have been associated with surgical outcomes. The investigators multidisciplinary team has substantial expertise and experience in OSA investigation, DISE, and upper airway MRI.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2014

Completed
8.8 years until next milestone

Study Start

First participant enrolled

May 8, 2023

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2023

Completed
Last Updated

August 14, 2023

Status Verified

May 1, 2023

Enrollment Period

Same day

First QC Date

July 29, 2014

Last Update Submit

August 8, 2023

Conditions

Keywords

obstructive sleep apneasleep apnea

Outcome Measures

Primary Outcomes (1)

  • Surgical results

    Surgical outcomes will be measured using sleep study outcomes (apnea-hypopnea index). The analysis will include evaluation of a potential association between surgical outcomes and both MRI and DISE measures.

    6 months

Secondary Outcomes (2)

  • Sleep-Related Quality of Life

    6 months

  • Daytime Sleepiness

    6 months

Study Arms (1)

MRI, DISE, and Surgery

All participants will undergo MRI and DISE prior to undergoing surgical treatment of obstructive sleep apnea.

Procedure: MRI, DISE, and Surgery

Interventions

MRI, DISE, and Surgery

MRI, DISE, and Surgery

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study participants will be adults with obstructive sleep apnea undergoing surgery. All participants will undergo magnetic resonance imaging (MRI) and drug-induced sleep endoscopy (DISE).

You may qualify if:

  • age ≥ 21 years; moderate to severe OSA (AHI ≥15 events/hour)
  • body mass index \<40 kg/m2.

You may not qualify if:

  • prior OSA surgery
  • known neurologic, cardiac, pulmonary, renal, or hepatic disorders
  • psychiatric problems except for treated depression or mild anxiety
  • co-existing sleep disorder other than OSA
  • other contraindication to DISE or MRI such as propofol allergy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keck Hospital of USC

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea Syndromes

Interventions

Magnetic Resonance SpectroscopySurgical Procedures, Operative

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2014

First Posted

August 1, 2014

Study Start

May 8, 2023

Primary Completion

May 8, 2023

Study Completion

May 8, 2023

Last Updated

August 14, 2023

Record last verified: 2023-05

Locations